Hannah Joseph Hospital Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 2,850,000(48%) | — | ₹1,995 Cr |
| NII (HNI) | — | 855,000 (14%) | — | ₹599 Cr |
| Retail | — | 1,995,000 (33%) | — | ₹1,397 Cr |
| Market Maker | — | 300,000 (5%) | — | ₹21 Cr |
| Σ Total | — | 6,000,000 (100%) | — | ₹42,000 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,500 | ₹105,000 |
| Retail (Max) | 13 | 19,500 | ₹1,365,000 |
| S-HNI (Min) | 14 | 21,000 | ₹1,470,000 |
| B-HNI (Min) | 67 | 100,500 | ₹7,035,000 |
Financial Statements Amount in ₹ Crore
| Metric | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue | 43 | 78 | 64 |
| EBITDA | 12 | 21 | 18 |
| Profit After Tax | 5 | 7 | 4 |
| Net Worth | 53 | 49 | 44 |
| Total Assets | 105 | 99 | 90 |
| Reserves & Surplus | 40 | 35 | 29 |
| Total Borrowing | 32 | 34 | 31 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Funding of capital expenditure for establishing Radiation Oncology Centre – 34.98
- General Corporate Purpose –
Company Overview
Incorporated in 2011, Hannah Joseph Hospital Limited is a healthcare provider offering exceptional medical services across various specialties.
The company is a multi-specialty healthcare provider in Madurai, situated on a 2-acre campus with a central air-conditioning and water heating system, offering a combined capacity of 150 beds.
The company focuses on Neurology, Cardiology, Psychiatry, and Trauma healthcare, understanding global nuances, customer culture, and medical professionals' needs, addressing the demand for quality and affordable healthcare services.
Services:
- Department of Neurosciences: Neurology, Neurosurgery
- Department of Cardio Sciences: Cardiology
- Department of Trauma Care: Orthopaedics, Oral & Maxillofacial Surgery
- Department of Psychiatry: Psychiatry
As of November 30, 2025, the company has 364 employees.
Competitive Strengths:
- Excellence in Neurosciences
- Advanced Cardiac Sciences
- Expertise in Orthopaedics and Traumatology
- Robust Emergency and Critical Care
- Commitment to Patient-Cantered Care
- Community Engagement and Outreach